Gilead sued over pricing of hepatitis C drug By: CNBC.com News December 10, 2014 at 15:37 PM EST Philadelphia's transit agency has filed a lawsuit against Gilead Sciences challenging the "exorbitant pricing" of its hepatitis C drug Sovaldi. Read More >> Related Stocks: Gilead Sciences